feed,title,long_url,short_url
Investors,Amylyx Crashes 26% As New ALS Drug Faces A Barrage Of Troubles,https://www.investors.com/news/technology/amlx-stock-crashes-as-patients-drop-off-als-drug-relyvrio/,https://da.gd/6VwAZh
Investors,"AstraZeneca Is Making A $2 Billion Bet To Rival Lilly, Novo In Obesity Drugs",https://www.investors.com/news/technology/azn-stock-astrazeneca-earnings-q3-2023/,https://da.gd/4BYu6
